Inventor

JIA XIAO-CHI

US57 patents

⚠️ This page may combine multiple inventors who share the name “JIA XIAO-CHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JIA XIAO-CHI

AGENSYS INC

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibodies and related molecules that bind to PSCA proteins

Antibodies and related molecules that bind to PSCA proteins

Antibodies and related molecules that bind to PSCA proteins

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA

Antibodies and related molecules that bind to 161P2F10B proteins

Antibodies and related molecules that bind to 161P2F10B proteins

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Antibodies and related molecules that bind to 161P2F10B proteins

Antibodies and related molecules that bind to 24P4C12 proteins

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

AMGEN FREMONT INC

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Nucleic acid molecules which encode antibodies that bind CD40

Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses

Antibodies to c-Met

Human monoclonal antibodies to epidermal growth factor receptor

Treatment methods using c-Met antibodies

Antibodies directed to PDGFD and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibody categorization based on binding characteristics

WEBER RICHARD

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

ABGENIX INC

Methods of treating cancer and enhancing immune responses with antibodies that bind CD40

Human monoclonal antibodies to epidermal growth factor receptor

Antibodies to CD40 and methods of treating cancer and enhancing immune responses

GUDAS JEAN

Antibodies that bind to PSCA proteins for diagnosis of cancer

Antibody drug conjugates (ADC) that bind to 24P4C12 proteins

Antibodies and related molecules that bind to PSCA proteins

MICHAUD NEIL R

Antibodies to c-Met

Antibodies to c-Met

JAKOBOVITS AYA

Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibodies and related molecules that bind to 161P2F10B proteins

PFIZER

Antibodies to CD40

CELL GENESYS INC

Packaging cell lines for adeno-associated viral vectors

BEDIAN VAHE

Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses

WALKER WYNN L

Antibody categorization based on binding characteristics

ABBOTT LAB

IL-18 binding proteins

XIAO FENG

Antibodies directed to GPNMB and uses thereof